Life Science Tech Summit: Speaker Interview
Duane Dumont
Vice President, Information Technology
NXSTAGE MEDICAL
Duane Dumont joined NxStage Medical Inc. in 2006 as the VP of IT and Security Officer. He has 25 years’ experience in the field of IT as well as a diverse background in Quality and Regulatory and Statistics. He is responsible for leading NxStage’s global technology strategy and managing overall IT operations. His initiatives include improving service delivery through embracing effective and efficient use of cloud technology; leading strategic initiatives to transform technology into a compute anywhere, anytime and on any device; and partnering with the business to ensure business goals are met.
Duane will be one of the distinguished speakers at the Life Science Tech Summit.
Why is the Life Science Tech Summit important for IT executives?
The Life Science Tech Summit is a great way to meet leaders in similar industries. As you talk to these leaders you get to ask questions about hot topics like security and how businesses are being innovative.
What is one thing you hope to learn or discuss with your peers at the Life Science Tech Summit?
How health care regulation is affecting operations and what they are doing about it to remain agile.
What initiatives are on the horizon for your team in 2017?
We are providing updates to our Any, Any, Any infrastructure (Any device, Anywhere, Any time). Another big focus will be streamlining our security model.
From your perspective, how has the role of a CIO changed?
The CIO is much more of a business partner now than at any other time in the past. You have to be involved in almost all aspects of the business and become part of any team for solutions. CIO’s have to align with a business’s goals and are critical to achieving them.
What are the 3 biggest factors impacting IT in the life science industry?
- Regulation
- Security
- General pace of change in technology
Where do you draw your technology inspiration from?
All industries. You can’t simply look at what others are doing in life sciences because, in general, we move at a slower pace.
